Dodick DW, Gottschalk C, Cady R, Hirman J, et al. Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing. Headache 2020 Nov 9. doi: 10.1111/head.14007.
PMID: 33165938